Foreign direct investment carve-out for medical devices establishes distinct FDI treatment separate from pharmaceuticals. Foreign direct investment policy for pharmaceuticals has been amended to carve out medical devices as a separate category with immediate effect, changing the regulatory treatment previously applied to medical devices and prompting amendments to the Foreign Exchange Management Regulations; Authorised Dealer Category I banks are to notify customers and the directions operate without prejudice to other statutory approvals.
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
Foreign direct investment carve-out for medical devices establishes distinct FDI treatment separate from pharmaceuticals.
Foreign direct investment policy for pharmaceuticals has been amended to carve out medical devices as a separate category with immediate effect, changing the regulatory treatment previously applied to medical devices and prompting amendments to the Foreign Exchange Management Regulations; Authorised Dealer Category I banks are to notify customers and the directions operate without prejudice to other statutory approvals.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.